- Report
- March 2024
- 187 Pages
Global
From €3283EUR$3,374USD£2,812GBP
€3648EUR$3,749USD£3,125GBP
- Report
- April 2024
- 299 Pages
Global
From €5303EUR$5,450USD£4,543GBP
- Report
- April 2024
- 179 Pages
Global
From €4816EUR$4,950USD£4,126GBP
- Report
- February 2024
- 204 Pages
Global
From €3503EUR$3,600USD£3,001GBP
- Report
- November 2023
- 190 Pages
Global
From €4768EUR$4,900USD£4,084GBP
- Clinical Trials
- April 2024
- 65 Pages
Global
From €1459EUR$1,500USD£1,250GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Clinical Trials
- April 2024
- 300 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Report
- September 2023
- 75 Pages
Global
From €3887EUR$3,995USD£3,330GBP
- Report
- February 2024
- 180 Pages
Global
From €4768EUR$4,900USD£4,084GBP
- Report
- March 2024
- 200 Pages
Global
From €4038EUR$4,150USD£3,459GBP
- Report
- January 2024
- 200 Pages
Global
From €4038EUR$4,150USD£3,459GBP
- Report
- October 2023
- 145 Pages
Global
From €10698EUR$10,995USD£9,164GBP
- Report
- January 2022
- 230 Pages
Global
From €4476EUR$4,600USD£3,834GBP
- Report
- January 2023
- 143 Pages
Global
From €2431EUR$2,499USD£2,083GBP
- Report
- January 2022
- 60 Pages
Global
From €3843EUR$3,950USD£3,292GBP
- Report
- February 2022
- 220 Pages
Global
From €9243EUR$9,500USD£7,918GBP
- Report
- January 2022
- 200 Pages
Global
From €7297EUR$7,500USD£6,251GBP
The Heart Failure Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat a variety of heart-related conditions. Heart Failure Drugs are used to treat heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. These drugs can help reduce symptoms, improve quality of life, and reduce the risk of death. Commonly used Heart Failure Drugs include ACE inhibitors, beta blockers, diuretics, and angiotensin receptor blockers. These drugs work by reducing the workload on the heart, improving blood flow, and reducing fluid buildup in the body.
Some companies in the Heart Failure Drug market include Pfizer, Novartis, Merck, Sanofi, and Bristol-Myers Squibb. Show Less Read more